John Pagel’s research offers hope with novel treatment combination for older patients
Nov. 9, 2009
| By Dean Forbes
For the first time, Fred Hutchinson Cancer Research Center Clinical Research Division investigators used a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options. Results of the study, led by Dr. John Pagel, appeared online Sept. 28 in the journal Blood.